Atabecestat (Synonyms: JNJ-54861911) |
رقم الكتالوجGC39341 |
Atabecestat (JNJ-54861911) هو مخترق قوي للدماغ ونشط فموياً في موقع سلائف بروتين الأميلويد مثبط إنزيم 1 (BACE1) ، ويحقق انخفاضًا قويًا وعاليًا في CSF Aβ
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1200493-78-2
Sample solution is provided at 25 µL, 10mM.
Atabecestat (JNJ-54861911) is a potent brain-penetrant and orally active β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor, achieves robust and high CSF Aβ reduction. Atabecestat (JNJ-54861911) is tolerated and displays a sustained pharmacokinetic (PK) and pharmacodynamic (PD) characteristics. Atabecestat (JNJ-54861911) has the potential for Alzheimer's Disease treatment[1].
[1]. Timmers M, et al. Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ-54861911, a potent oral BACE inhibitor.Alzheimers Dement (N Y). 2016 Aug 24;2(3):202-212.
Average Rating: 5
(Based on Reviews and 15 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *